Zymeworks' Debt Round

Zymeworks raised a round of funding on June 16, 2009. Investors include CTI Life Sciences Fund.

Zymeworks (NYSE: ZYME) (TSX: ZYME) is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of multifunctional biotherapeutics.…

Articles about Zymeworks' Debt Round: